THE INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
First IMI Ebola projects get underway
IMI is launching the first eight projects of its Ebola+ programme, covering vaccine development, manufacture and uptake as well as diagnostics.
- Read the press release
- 26/01/2015 : RT @WEBRADR: Pertinent to #webradr & anyone interested in #mhealth or #ehealth - consultation report by @DigitalAgendaEU http://t.co/NlbfzB…
- 26/01/2015 : Calling all #auditors – IMI is hiring! Deadline 15 Feb. http://t.co/D5K4TpNKD7 #jobs #Brussels
- 26/01/2015 : RT @SwissCore: A Swiss Science Lecture on Ebola on 27 January 2015 with Marcel Tanner, Blaise Genton and Vasee Moorthy. Register: http://t.…